Value of of Earlier Lipid-Lowering therapy Intensification with Evolocumab in High-Risk Populations without known significant ASCVD and with Diabetes: VESALIUS-CV Insights
Value of of Earlier Lipid-Lowering therapy Intensification with Evolocumab in High-Risk Populations without known significant ASCVD and with Diabetes: VESALIUS-CV Insights